Tirzepatide is a prescription medication approved by the FDA in November 2023 for weight management in obese or overweight adults with at least one weight-related condition (U.S
Do you have any doubts
Prevencin de complicaciones cardiovasculares : Estudios preliminares indican que la tirzepatida puede reducir el riesgo de eventos cardiovasculares mayores, como ataques cardacos y accidentes cerebrovasculares, lo cual es crucial en pacientes con diabetes tipo 2
However, it seems that amelanotic melanoma occurs in some types more than others
Imad El Asmar, part of your care includes careful evaluation of medical history, ongoing monitoring for side effects, and direct support to ensure safety throughout the treatment process
Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Insulin Glargine as Add-on to Metformin (With or Without Sulfonylureas) in Insulin-Naive Patients With Type 2 Diabetes (SUSTAIN 4): A Randomised, Open-Label, Parallel-Group, Multicentre, Mul